Clinical and hematological profile and outcomes of children with dengue infection: a prospective observational study

Chaitanya Rajendra Bhattad; Smita Priyadarshan Jategaonkar; Manish Jain; Ruchika Kinnake

doi:10.18203/2349-3291.ijcp20263814

Authors

Chaitanya Rajendra Bhattad Department of Paediatrics, Mahatma Gandhi Institute of Medical Sciences, Wardha, Maharashtra, India
Smita Priyadarshan Jategaonkar Department of Paediatrics, Mahatma Gandhi Institute of Medical Sciences, Wardha, Maharashtra, India
Manish Jain Department of Paediatrics, Mahatma Gandhi Institute of Medical Sciences, Wardha, Maharashtra, India
Ruchika Kinnake Department of Paediatrics, Mahatma Gandhi Institute of Medical Sciences, Wardha, Maharashtra, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20263814

Keywords:

Dengue, Children, Severe dengue, Hematological profile, Thrombocytopenia, NS1 antigen

Abstract

Background: Dengue is an important cause of morbidity among children in tropical countries, with clinical manifestations ranging from a self-limiting febrile illness to severe dengue associated with plasma leakage, shock, and organ dysfunction. Early identification of children at risk of severe disease is essential for prompt management and improved outcomes. The present study aimed to evaluate the clinical and hematological profile of pediatric dengue infection and determine its association with disease severity and clinical outcomes.

Methods: This prospective observational study was conducted in the Department of Pediatrics at a rural tertiary-care teaching hospital in Maharashtra, India, between September 2022 and February 2024. A total of 195 children aged 0-13 years with laboratory-confirmed dengue infection (positive NS1 antigen and/or dengue IgM antibody) were enrolled consecutively. Patients were classified according to the World Health Organization (WHO) 2009 dengue classification into dengue fever (DF), dengue fever with warning signs (DFWS), and severe dengue. Clinical characteristics, laboratory parameters, treatment received, duration of hospitalization, and outcomes were analyzed. Results: Out of the 195 children, 156 (80.0%) had DF, 28 (14.4%) had DFWS, and 11 (5.6%) had severe dengue. Increasing age was significantly associated with disease severity (p<0.05), whereas sex distribution was comparable across groups (p=0.81). Bleeding manifestations (p<0.001), nausea/vomiting (p<0.001), abdominal pain (p<0.001), myalgia (p=0.013), hepatomegaly (p=0.001), ascites (p=0.001), and shock (p<0.001) were significantly associated with severe disease. Progressive thrombocytopenia, lower nadir platelet count, higher total leukocyte count, and increased highest packed cell volume were significantly associated with disease severity (all p<0.05). NS1 antigen positivity showed a significant association with severe disease (p<0.01), whereas dengue IgM positivity did not (p=0.56). Increasing disease severity was associated with greater requirements for intravenous fluids, plasma transfusion, platelet transfusion, inotropic support, and longer hospital stay (all p<0.01). All children recovered, and no mortality was observed.

Conclusions: Older age, gastrointestinal symptoms, bleeding manifestations, hepatomegaly, ascites, shock, thrombocytopenia, leukocytosis, and elevated packed cell volume were significantly associated with severe dengue in children. Careful clinical assessment together with serial hematological monitoring remains essential for early recognition of severe dengue and timely institution of supportive management, contributing to favorable clinical outcomes.

References

Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496(7446):504-7.

Stanaway JD, Shepard DS, Undurraga EA, Halasa YA, Coffeng LE, Brady OJ, et al. The global burden of dengue: an analysis from the Global Burden of Disease Study 2013. Lancet Infect Dis. 2016;16(6):712-23.

Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev. 1998;11(3):480-96.

Gould EA, Solomon T. Pathogenic flaviviruses. Lancet. 2008;371(9611):500-9.

Sharp TM, Fischer M, Muñoz-Jordán JL, Paz-Bailey G, Staples JE, Gregory CJ, et al. Dengue and Zika virus diagnostic testing for patients with a clinically compatible illness and risk for infection with both viruses. MMWR Recomm Rep. 2019;68(1):1-10.

Chakravarti A, Arora R, Luxemburger C. Fifty years of dengue in India. Trans R Soc Trop Med Hyg. 2012;106(5):273-82.

Murhekar MV, Kamaraj P, Kumar MS, Khan SA, Allam RR, Barde P, et al. Burden of dengue infection in India, 2017: a cross-sectional population-based serosurvey. Lancet Glob Health. 2019;7(8):e1065-73.

World Health Organization. Dengue: guidelines for diagnosis, treatment, prevention and control. New edition. Geneva: World Health Organization; 2009. Available at: https://www.who.int/publications/i/item/9789241547871 Accessed on 30 August 2026.

Lovera D, Martínez-Cuellar C, Galeano F, Amarilla S, Vazquez C, Arbo A. Clinical manifestations of primary and secondary dengue in Paraguay and its relation to virus serotype. J Infect Dev Ctries. 2019;13(12):1127-34.

Prasad D, Bhriguvanshi A. Clinical Profile, Liver Dysfunction and Outcome of Dengue Infection in Children: A Prospective Observational Study. Pediatr Infect Dis J. 2020;39(2):97-101.

Sachdev A, Pathak D, Gupta N, Simalti A, Gupta D, Gupta S, Chugh P. Early Predictors of Mortality in Children with Severe Dengue Fever: A Prospective Study. Pediatr Infect Dis J. 2021;40(9):797-801.

Arora SK, Nandan D, Sharma A, Benerjee P, Singh DP. Predictors of severe dengue amongst children as per the revised WHO classification. J Vector Borne Dis. 2021;58(4):329-34.

Khan A, Durrani A, Alam S, Gul M. Frequency of thrombocytopenia in children presented with dengue fever. Khyber J Med Sci. 2024;17(3):122-6.

Karotkar S, Lakra MS, Lakra A, Lakhkar B. To study the clinical presentation, laboratory parameters and predictors of severity in dengue fever in children in a Metropolitan City in India. Sri Lanka J Child Health. 2022;51(3):404–11.

Mishra S, Ambey R, Khare A, Gaur A. Clinico-epidemiological profile of dengue in children of age group 0-14 years admitted in a tertiary care hospital. Cureus. 2025;17(6):e87027.

Islam A, Iqbal MJ, Islam MMDZ, Begum S. Clinical and hematological profiles of dengue in children. TAJ J. 2024;37(1):208-18.

Sontakke RA, Aglave NR, Dua H. Correlation of platelet parameters with the severity of thrombocytopenia in dengue fever in children aged less than 18 years at a tertiary care centre: a cross-sectional study. Cureus. 2024;16(3):e56829.

Krishna MS, Cherian R, Jose BJ. Early hematological parameters as predictors for outcomes in children with dengue in Southern India: a retrospective analysis. J Cardiovasc Dis Res. 2024;15(6):3758-67.

Srinivas SA, Pol R. Study of clinical profile and laboratory markers in early diagnosis of severe dengue in children. Int J Contemp Pediatr. 2025;12(1):73-7.